SCHEMBL3817014

SCHEMBL3817014

COc1ccc(-c2sc3c(c2CN(C)Cc2ccccc2)c(=O)c(C(=O)O)cn3Cc2ccccc2OC)cc1

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7011733 0.94 GNRHR (0.83) GNRHR
SCHEMBL7009918 0.94 GNRHR (0.82) GNRHR
SCHEMBL7006519 0.94 GNRHR (0.82) GNRHR
Hydrochloric Acid SCHEMBL7012613 0.93 GNRHR (0.81) GNRHR
SCHEMBL3821372 0.92 GNRHR (0.80) GNRHR
SCHEMBL7010113 0.92 GNRHR (1.00) GNRHR
Hydrochloric Acid SCHEMBL7498872 0.91 GNRHR (0.98) GNRHR
SCHEMBL7497714 0.91 GNRHR (0.71) GNRHR
SCHEMBL7005234 0.90 GNRHR (0.77) GNRHR
SCHEMBL7100017 0.90 GNRHR (0.79) GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0781774-B1 Prolactin production inhibitory agents TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-07-31 EP claimed
EP-1520855-B1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone ORTHO MCNEIL JANSSEN PHARM (US) 2009-12-02 EP disclosed
EP-1345907-B1 7-HETEROCYCLYL QUINOLINE AND THIENO 2,3-B|PYRIDINE DERIVATIVES USEFUL AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE ORTHO MCNEIL PHARM INC (US) 2006-08-23 EP disclosed
EP-1520855-A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone Ortho-Mcneil Pharmaceutical, Inc. (US) 2005-04-06 EP disclosed
US-6765011-B2 ANTICANCER AGENTS; BEGNIN PROSTATE GLANDS; CONTRACEPTIVES ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-07-20 US disclosed
US-20030216429-A1 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone SUI ZHIHUA (US) 2003-11-20 US disclosed
EP-1345907-A2 7-HETEROCYCLYL QUINOLINE AND THIENO 2,3-B]PYRIDINE DERIVATIVES USEFUL AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Ortho-Mcneil Pharmaceutical, Inc. (US) 2003-09-24 EP disclosed
US-6583153-B2 Treating infertility, prostate cancer and benign prostate hyperplasia (BPH) ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-06-24 US disclosed
US-20020123506-A1 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-09-05 US disclosed
WO-2002048112-A2 7-HETEROCYCLYL QUINOLINE AND THIENO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216429-A1 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone GNRHR, FSHR, LHCGR GNRHR 1/4885
US-20020123506-A1 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone GNRHR, FSHR, LHCGR GNRHR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.